rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3-4
|
pubmed:dateCreated |
1999-7-15
|
pubmed:abstractText |
Sarcoma botryoides of the cervix is an extremely rare tumour and seems to be associated with a better prognosis than its vaginal counterpart. Recent studies have suggested that it is possible to limit surgery to local excision in stage I cases. We report three cases of young subjects treated successfully with polypectomy or diathermy loop excision followed by adjuvant chemotherapy. One patient had a local recurrence which was treated with further local excision. All subjects remain alive without evidence of recurrence and with normal menstrual function 36, 38 and 38 months following initial diagnosis. A conservative surgical approach to early cervical sarcoma botryoides is possible. The efficacy of adjuvant chemotherapy and the regimen of choice still need to be investigated.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-1090863,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-1111936,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-13618859,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-2294394,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-2403958,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-3278956,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-3621128,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-3758828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-3910785,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-4202189,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-5231254,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-7622119,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-762607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10408845-9571003
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0007-0920
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
403-6
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10408845-Adult,
pubmed-meshheading:10408845-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10408845-Chemotherapy, Adjuvant,
pubmed-meshheading:10408845-Combined Modality Therapy,
pubmed-meshheading:10408845-Doxorubicin,
pubmed-meshheading:10408845-Female,
pubmed-meshheading:10408845-Humans,
pubmed-meshheading:10408845-Ifosfamide,
pubmed-meshheading:10408845-Rhabdomyosarcoma, Embryonal,
pubmed-meshheading:10408845-Uterine Cervical Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females.
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, San Gerardo Hospital of Monza, Third Branch of the University of Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Case Reports
|